SEC Form 4 · accession 0001144204-16-136385

Altimmune, Inc. · ALT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Nov 22, 2016

Accepted (ET)

Nov 23, 2016 · 4:46 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001326190

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock, $0.0001 par value per share	Nov 22, 2016	M	30,573	$2.46	A	444,895	D
Common Stock, $0.0001 par value per share	Nov 22, 2016	M	37,500	$1.19	A	482,395	D
Common Stock, $0.0001 par value per share	Nov 22, 2016	M	240,000	$1.94	A	722,395	D
Common Stock, $0.0001 par value per share	Nov 22, 2016	M	135,660	$1.71	A	858,055	D
Common Stock, $0.0001 par value per share	Nov 22, 2016	M	20,000	$1.69	A	878,055	D
Common Stock, $0.0001 par value per share	Nov 22, 2016	M	20,000	$2.20	A	898,055	D
Common Stock, $0.0001 par value per share^F1	holding	—	—		—	10,000	I	See Footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Stock Option (right to buy)	$2.46	Nov 22, 2016	M	30,573	D	Jan 21, 2010	Jan 21, 2019	Common Stock	30,573	D
Stock Option (right to buy)	$1.19	Nov 22, 2016	M	37,500	D	Dec 12, 2013	Dec 12, 2022	Common Stock	37,500	D
Stock Option (right to buy)	$1.94	Nov 22, 2016	M	240,000	D	Jan 29, 2015	Jan 29, 2024	Common Stock	240,000	D
Stock option (right to buy)	$1.71	Nov 22, 2016	M	135,660	D	Dec 11, 2015	Dec 11, 2024	Common Stock	135,660	D
Stock option (right to buy)	$1.69	Nov 22, 2016	M	20,000	D	Aug 2, 2016	Aug 1, 2025	Common Stock	20,000	D
Stock option (right to buy)	$2.20	Nov 22, 2016	M	20,000	D	Jun 1, 2017	May 31, 2026	Common Stock	20,000	D